New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

If the younger person with dementia or other people dismiss early and mild symptoms ... behaviour and ability to do daily tasks a full physical exam at least one brain scan (often with more specialist ...

Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ...

The Brain Tour, inside dementia is an app designed for iOS and Android phones, that uses augmented reality to transport users inside the brain. Whether you're curious to explore a healthy brain or ...